IDE Study
i-FACTOR Bone Graft shown to be superior to autograft based on analysis of patient response to all four clinical endpoints from the pivotal IDE trial!
LEARN MOREMechanism of Action
Key to choosing the appropriate graft material is an understanding of how it works. Learn more about the natural process and what to expect from i-FACTOR Bone Graft.
LEARN MOREPre-Clinical Evidence
Studies have shown that P-15, in combination with ABM, mimics the behavior of autograft bone. Learn more about the depth of scientific research supporting this novel bone graft.
Learn MoreHow i-FACTOR Bone Graft Compares to Other Bone Grafts
At Cerapedics, we are focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology (P-15) on anorganic bone mineral (ABM), supported by the highest level of clinical evidence, and validated in clinically relevant real world applications.
In the lecture presentation “Bone Grafting Options & Evidence”, company President and COO Jeff Marx analyzes the market for bone void fillers and bone graft substitutes. Dr. Marx uses the broader bone grafting market to introduce i-FACTOR Bone Graft and explain why it is a novel and advanced biologic.
For additional information on the world of bone grafts and what sets i-FACTOR Bone Graft apart, Explore Here.